Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for ASTH

Show aggregate ASTH holdings

News associated with ASTH

Rep. Judy Chu Buys Astrana Health, Inc. (NASDAQ:ASTH) Shares

Representative Judy Chu (D-California) recently bought shares of Astrana Health, Inc. (NASDAQ:ASTH). In a filing disclosed on August 30th, the Representative disclosed that they had bought between $100,001 and $250,000 in Astrana Health stock on August 19th. Representative Judy Chu also recently made the following trade(s): Sold $100,001 – $250,000 in shares of Astrana Health […] - 2025-09-02 03:03:14

Reviewing Astrana Health (NASDAQ:ASTH) & The Pennant Group (NASDAQ:PNTG)

Astrana Health (NASDAQ:ASTH – Get Free Report) and The Pennant Group (NASDAQ:PNTG – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Institutional and Insider Ownership 52.8% of […] - 2025-08-26 05:34:53

Critical Comparison: Astrana Health (NASDAQ:ASTH) and Fresenius SE & Co. (OTCMKTS:FSNUY)

Astrana Health (NASDAQ:ASTH – Get Free Report) and Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Analyst Recommendations This is a summary […] - 2025-08-19 04:26:49

Noteworthy Monday Option Activity: ASTH, PLTR, INTC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Astrana Health Inc (Symbol: ASTH), where a total volume of 5,461 contracts has been traded thus far today, a contract volume which is representative of approxima - 2025-08-18 16:18:40

Maryland State Retirement & Pension System Has $375,000 Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

Maryland State Retirement & Pension System lowered its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 13.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,099 shares of the company’s stock after selling 1,927 shares during […] - 2025-08-17 05:17:02

Natixis Advisors LLC Grows Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Natixis Advisors LLC lifted its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,622 shares of the company’s stock after purchasing an additional 3,462 shares during the […] - 2025-08-11 05:12:52

Bank of New York Mellon Corp Sells 13,624 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Bank of New York Mellon Corp lessened its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 5.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 253,252 shares of the company’s stock after selling 13,624 shares during the period. Bank of […] - 2025-07-23 05:08:52

Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System decreased its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 2.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,600 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State […] - 2025-07-21 05:16:48

Reviewing Astrana Health (NASDAQ:ASTH) & Montrose Environmental Group (NYSE:MEG)

Montrose Environmental Group (NYSE:MEG – Get Free Report) and Astrana Health (NASDAQ:ASTH – Get Free Report) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings. Analyst Recommendations This is a […] - 2025-06-10 02:58:49

Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Rating of “Moderate Buy” from Analysts

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine brokerages that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year target price among brokers […] - 2025-06-10 02:28:55

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 15.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 104,658 shares of the company’s stock after acquiring an additional 14,138 shares during the period. UBS AM a distinct […] - 2025-06-06 05:16:54

Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by BNP Paribas Financial Markets

BNP Paribas Financial Markets lowered its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 43.0% during the fourth quarter, Holdings Channel.com reports. The fund owned 5,638 shares of the company’s stock after selling 4,249 shares during the quarter. BNP Paribas Financial Markets’ holdings in Astrana Health were worth $178,000 at the end of […] - 2025-05-30 04:27:00

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Position in Astrana Health, Inc. (NASDAQ:ASTH)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 3.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 24,505 shares of the company’s stock after buying an additional 915 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-28 04:50:54

State of Wyoming Lowers Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

State of Wyoming lessened its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 53.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,873 shares of the company’s stock after selling 4,421 shares during the period. […] - 2025-05-27 05:18:56

Astrana Health, Inc. (NASDAQ:ASTH) Shares Acquired by Northern Trust Corp

Northern Trust Corp lifted its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 10.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 467,179 shares of the company’s stock after acquiring an additional 43,032 shares during the quarter. Northern Trust Corp’s holdings in Astrana Health were worth $14,730,000 as of its most recent […] - 2025-05-16 05:20:50

Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Rating of “Moderate Buy” by Brokerages

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been given a consensus rating of “Moderate Buy” by the ten research firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-16 02:59:04

Astrana Health, Inc. (NASDAQ:ASTH) Position Reduced by Voya Investment Management LLC

Voya Investment Management LLC reduced its position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 7.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 13,038 shares of the company’s stock after selling 979 shares during the quarter. Voya Investment […] - 2025-05-11 06:06:57

Dimensional Fund Advisors LP Buys 101,192 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Dimensional Fund Advisors LP lifted its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 10.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,045,540 shares of the company’s stock after buying an additional 101,192 shares during the quarter. Dimensional […] - 2025-05-06 04:59:00

First Trust Advisors LP Has $3.39 Million Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

First Trust Advisors LP increased its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 702.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 107,343 shares of the company’s stock after buying an additional 93,969 shares during the quarter. First Trust […] - 2025-05-04 05:30:52

Astrana Health, Inc. (NASDAQ:ASTH) Shares Purchased by Wells Fargo & Company MN

Wells Fargo & Company MN boosted its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 41.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,484 shares of the company’s stock after buying an additional 6,596 shares […] - 2025-05-02 05:00:57

Barclays PLC Buys 2,627 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Barclays PLC increased its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,543 shares of the company’s stock after buying an additional 2,627 shares during the quarter. Barclays PLC’s […] - 2025-05-01 05:12:57

Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $53.29

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating […] - 2025-04-24 02:10:51

Astrana Health, Inc. (NASDAQ:ASTH) Stock Position Decreased by Corebridge Financial Inc.

Corebridge Financial Inc. lowered its holdings in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 7.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 22,890 shares of the company’s stock after selling 1,784 shares during the period. Corebridge Financial Inc.’s holdings in Astrana Health were worth $722,000 as of its most recent filing with […] - 2025-04-07 04:32:48

Astrana Health (NASDAQ:ASTH) Coverage Initiated at Barclays

Equities researchers at Barclays initiated coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage set an “equal weight” rating and a $36.00 price target on the stock. Barclays‘s price objective suggests a potential upside of 19.92% from the company’s current […] - 2025-04-03 02:54:45

Thrivent Financial for Lutherans Sells 487 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Thrivent Financial for Lutherans reduced its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 32,130 shares of the company’s stock after selling 487 shares during the period. Thrivent Financial for Lutherans’ holdings in […] - 2025-04-02 05:14:57

Natixis Advisors LLC Has $762,000 Position in Astrana Health, Inc. (NASDAQ:ASTH)

Natixis Advisors LLC cut its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 13.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,160 shares of the company’s stock after selling 3,820 shares during the period. Natixis Advisors LLC’s holdings in Astrana Health […] - 2025-03-27 07:08:51

Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 348.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 37,788 shares of the company’s stock after purchasing an additional 29,355 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank […] - 2025-03-20 06:22:51

Truist Financial Lowers Astrana Health (NASDAQ:ASTH) Price Target to $46.00

Astrana Health (NASDAQ:ASTH – Get Free Report) had its price objective reduced by equities research analysts at Truist Financial from $50.00 to $46.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price points to a potential upside of 45.99% from the company’s […] - 2025-03-20 03:52:45

Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Down 23.0% in February

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 1,440,000 shares, a drop of 23.0% from the February 13th total of 1,870,000 shares. Based on an average daily volume of 346,500 shares, the short-interest ratio […] - 2025-03-17 04:10:45

Critical Analysis: Astrana Health (NASDAQ:ASTH) and Exponent (NASDAQ:EXPO)

Astrana Health (NASDAQ:ASTH – Get Free Report) and Exponent (NASDAQ:EXPO – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings. Earnings and Valuation This table compares Astrana Health and […] - 2025-03-10 04:08:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ASTH holdings

Date	Number of ASTH Shares Held	Base Market Value of ASTH Shares	Local Market Value of ASTH Shares	Change in ASTH Shares Held	Change in ASTH Base Value	Current Price per ASTH Share Held	Previous Price per ASTH Share Held
2025-09-26 (Friday)	6,114	USD 181,464	USD 181,464
2025-09-25 (Thursday)	6,114	USD 170,458	USD 170,458	0	USD -1,223	USD 27.8799	USD 28.08
2025-09-24 (Wednesday)	6,114	USD 171,681	USD 171,681
2025-09-17 (Wednesday)	6,076	USD 176,690	USD 176,690	0	USD -3,828	USD 29.08	USD 29.71
2025-09-16 (Tuesday)	6,076	USD 180,518	USD 180,518
2025-09-12 (Friday)	6,038	USD 180,114	USD 180,114
2025-09-11 (Thursday)	6,038	USD 183,434	USD 183,434	76	USD 7,495	USD 30.3799	USD 29.5101

Share Trades of ASTH by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-11	BUY	76			30.380*		33.29
2025-08-21	SELL	-19			29.970*		33.31 Profit of 633 on sale
2025-07-31	BUY	57			23.860*		33.39
2025-06-30	SELL	-38			24.880*		34.57 Profit of 1,314 on sale
2025-06-25	SELL	-19			25.040*		34.77 Profit of 661 on sale
2025-06-20	SELL	-38			24.000*		34.98 Profit of 1,329 on sale
2025-05-23	BUY	19			24.290*		36.62
2025-05-19	SELL	-19			26.850*		36.99 Profit of 703 on sale
2025-05-15	SELL	-57			27.060*		37.16 Profit of 2,118 on sale
2025-05-12	SELL	-19			28.540*		37.42 Profit of 711 on sale
2025-05-09	SELL	-19			29.710*		37.49 Profit of 712 on sale
2025-04-30	SELL	-19			31.170*		37.85 Profit of 719 on sale
2025-04-24	SELL	-38			31.400*		38.13 Profit of 1,449 on sale
2025-04-17	SELL	-19			31.380*		38.52 Profit of 732 on sale
2025-04-15	SELL	-57			33.760*		38.63 Profit of 2,202 on sale
2025-04-14	SELL	-57			34.050*		38.68 Profit of 2,205 on sale
2025-04-09	SELL	-76			31.930*		38.89 Profit of 2,956 on sale
2025-04-07	SELL	-133			29.290*		39.09 Profit of 5,199 on sale
2025-04-04	SELL	-190			30.070*		39.20 Profit of 7,447 on sale
2025-03-31	BUY	19			31.010*		39.52
2025-03-19	SELL	-38			31.510*		40.42 Profit of 1,536 on sale
2025-03-14	SELL	-114			29.340*		40.83 Profit of 4,654 on sale
2025-03-13	SELL	-38			29.195*		40.99 Profit of 1,558 on sale
2025-03-12	SELL	-646			29.660*		41.15 Profit of 26,584 on sale
2025-03-07	SELL	-38			29.380*		41.70 Profit of 1,585 on sale
2025-03-06	SELL	-57			27.210*		41.92 Profit of 2,390 on sale
2025-03-03	SELL	-19			26.480*		42.64 Profit of 810 on sale
2025-02-28	SELL	-114			25.380*		42.92 Profit of 4,893 on sale
2025-02-26	SELL	-19			35.100*		43.19 Profit of 821 on sale
2025-02-25	SELL	-57			35.370*		43.32 Profit of 2,469 on sale
2025-02-18	BUY	95			38.900*		43.99
2025-02-13	BUY	19			39.200*		44.28
2025-02-12	BUY	19			38.380*		44.40
2025-02-11	BUY	57			38.040*		44.54
2025-02-06	BUY	171			35.580*		45.10
2025-01-27	BUY	19			37.720*		46.85
2024-12-30	BUY	95			31.980*		48.31
2024-12-06	BUY	76			41.410*		49.11
2024-12-05	BUY	19			42.900*		49.33
2024-12-04	BUY	95			43.420*		49.54
2024-11-29	BUY	95			43.250*		50.23
2024-11-27	BUY	76			42.860*		50.88
2024-11-26	BUY	19			42.460*		51.26
2024-11-21	BUY	95			42.110*		52.69
2024-11-20	BUY	57			41.040*		53.33
2024-11-18	BUY	228			40.510*		54.91
2024-11-12	BUY	152			42.910*		55.71
2024-11-08	BUY	95			46.960*		56.34
2024-11-07	BUY	285			59.080*		56.12
2024-11-06	BUY	38			59.490*		55.84
2024-10-31	BUY	19			53.780*		56.44

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ASTH

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer